Karen Valentine - Net Worth and Insider Trading

Karen Valentine Net Worth

The estimated net worth of Karen Valentine is at least $58,882 dollars as of 2024-03-28. Karen Valentine is the Chief Legal Officer of Agenus Inc and owns about 101,521 shares of Agenus Inc (AGEN) stock worth over $58,882. Karen Valentine is also the See Remarks of Constellation Pharmaceuticals Inc and owns about 0 shares of Constellation Pharmaceuticals Inc (CNST) stock worth over $0. Details can be seen in Karen Valentine's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Karen Valentine has not made any transactions after 2021-01-19 and currently still holds the listed stock(s).

Transaction Summary of Karen Valentine

To

Karen Valentine Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karen Valentine owns 2 companies in total, including Constellation Pharmaceuticals Inc () , and Agenus Inc () .

Click here to see the complete history of Karen Valentine’s form 4 insider trades.

Insider Ownership Summary of Karen Valentine

Ticker Comapny Transaction Date Type of Owner
Constellation Pharmaceuticals Inc 2021-01-19 See Remarks
Agenus Inc 2017-12-12 Chief Legal Officer

Karen Valentine Latest Holdings Summary

Karen Valentine currently owns a total of 2 stocks. Among these stocks, Karen Valentine owns 101,521 shares of Agenus Inc (AGEN) as of December 12, 2017, with a value of $58,882 and a weighting of 100%. Karen Valentine also owns 0 shares of Constellation Pharmaceuticals Inc (CNST) as of January 19, 2021, with a value of $0 and a weighting of 0%.

Latest Holdings of Karen Valentine

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AGEN Agenus Inc 2017-12-12 101,521 0.58 58,882
CNST Constellation Pharmaceuticals Inc 2021-01-19 0 33.99 0

Holding Weightings of Karen Valentine


Karen Valentine Form 4 Trading Tracker

According to the SEC Form 4 filings, Karen Valentine has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the sale of 8,358 shares on December 12, 2017, which brought Karen Valentine around $28,919.

According to the SEC Form 4 filings, Karen Valentine has made a total of 10 transactions in Constellation Pharmaceuticals Inc (CNST) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Constellation Pharmaceuticals Inc is the sale of 17,203 shares on January 19, 2021, which brought Karen Valentine around $584,386.

Insider Trading History of Karen Valentine

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Karen Valentine Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Karen Valentine Ownership Network

Ownership Network List of Karen Valentine

No Data

Ownership Network Relation of Karen Valentine


Karen Valentine Owned Company Details

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

Karen Valentine is the See Remarks of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and director & 10 percent owner Mark A Goldsmith .

Constellation Pharmaceuticals Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

Karen Valentine Mailing Address

Above is the net worth, insider trading, and ownership report for Karen Valentine. You might contact Karen Valentine via mailing address: C/o Antigenics Inc., 3 Forbes Rd, Lexington Ma 02421.

Discussions on Karen Valentine

No discussions yet.